Bass Takes Aim At Citius Drug Patent Under His Own Name

By Ryan Davis (November 25, 2015, 5:36 PM EST) -- Hedge fund manager Kyle Bass and self-described "patent troll" Erich Spangenberg challenged another drug patent Tuesday, this time taking aim at Citius Pharmaceuticals Inc.'s obesity drug Suprenza with an inter partes review petition filed under their own names, rather than the group they formed to challenge other patents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!